cognitive impairment in schizophrenia therapeutic (Eli Lilly)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namecognitive impairment in schizophrenia therapeutic (Eli Lilly)
Drug Alias NameNCE (Eli Lilly)anti-obesity small molecule (Eli Lilly)NCE (Eli Lilly)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAppetite suppressant
TargetsUpdating
Therapy Area/IndicationsCognition DisordersObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEli Lilly And Company
Active IndicationsN/A
Inactive IndicationsCognition DisordersObesity

Other Information

ATC CodeN/A
Related LinksN/A